ABBV AbbVie Inc

154.8627
2.12 (1.39%)
Sep 25 2023 - Closed
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.

Period:

Draw Mode:

Volume 3,740,017
Bid Price
Ask Price
News (2)
Day High 154.74

Low
130.9601

52 Week Range

High
168.11

Day Low 151.66
Company Name Stock Ticker Symbol Market Type
AbbVie Inc ABBV NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
2.12 1.39% 154.8627 20:00:00
Open Price Low Price High Price Close Price Prev Close
152.74 151.66 154.74 154.65 152.74
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
54,275 3,740,017 $ 153.75 $ 575,011,831 - 130.9601 - 168.11
Last Trade Time Type Quantity Stock Price Currency
19:53:38 1 $ 154.50 USD

AbbVie (ABBV) Options Flow Summary

Overall Flow

Bullish

Net Premium

826k

Calls / Puts

300.00%

Buys / Sells

81.82%

OTM / ITM

33.33%

Sweeps Ratio

0.00%

AbbVie Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
273.34B 1.77B - 58.05B 11.84B 6.71 23.05
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

AbbVie News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ABBV Message Board. Create One! See More Posts on ABBV Message Board See More Message Board Posts

Historical ABBV Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week153.08154.88151.60153.443,185,1731.781.16%
1 Month147.09154.88143.74150.134,103,3657.775.28%
3 Months134.19154.88132.70145.924,717,05720.6715.41%
6 Months158.51166.20130.9601145.855,201,737-3.65-2.3%
1 Year142.08168.11130.9601149.175,564,84512.789.0%
3 Years86.00175.9179.1101129.926,522,88668.8680.07%
5 Years93.48175.9162.55107.957,210,05761.3865.66%

AbbVie Description

AbbVie Inc. is a pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. The company's primary product is Humira, administered via injection.